TRO 19622

TRO 19622 Structure
TRO 19622 structure
Common Name TRO 19622
CAS Number 22033-87-0 Molecular Weight 399.65200
Density 1.1 Boiling Point 510ºC at 760mmHg
Molecular Formula C27H45NO Melting Point 145-148ºC
MSDS USA Flash Point 341ºC

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.

J. Pharmacol. Exp. Ther. 322 , 709-720, (2007)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive death of cortical and spinal motor neurons, for which there is no effective treatment. Using a cell-based assay for compounds capable of preventing motor ne...

The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation.

J. Neurosci. 31(1) , 359-70, (2011)

Ablation of mouse occipital cortex induces precisely timed and uniform p53-modulated and Bax-dependent apoptosis of thalamocortical projection neurons in the dorsal lateral geniculate nucleus (LGN) by 7 d after lesion. We tested the hypothesis that this neuro...

Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.

J. Pharmacol. Exp. Ther. 326(2) , 623-32, (2008)

Diabetes and cancer chemotherapies are often associated with painful neuropathy. The mechanisms underlying neuropathic pain remain poorly understood, and the current therapies have limited efficacy and are associated with dose-limiting side effects. We recent...

TRO19622 promotes myelin repair in a rat model of demyelination.

Int. J. Neurosci. , (2013)

Multiple sclerosis is a neurodegenerative autoimmune disease characterized by diffuse oligodendrocyte injury, axonal loss and multifocal demyelination of myelin sheaths in the central nervous system. TRO19622 is a small cholesterol-like compound, which displa...

Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.

Toxicol. Appl. Pharmacol. 240(3) , 348-54, (2009)

Thiazolidinediones (TZDs), such as troglitazone (TRO) and rosiglitazone (ROSI), improve insulin resistance by acting as ligands for the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma). TRO was withdrawn from the market because of...